Actinium Pharmaceuticals
ATNM
ATNM
27 hedge funds and large institutions have $5.65M invested in Actinium Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
0.12% less ownership
Funds ownership: 0.34% → 0.22% (-0.12%)
10% less funds holding
Funds holding: 30 → 27 (-3)
Holders
27
Holding in Top 10
–
Calls
$48K
Puts
$8K
Top Buyers
| 1 | +$1.06M | |
| 2 | +$694K | |
| 3 | +$66K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$42.6K |
| 5 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
+$24.2K |
Top Sellers
| 1 | -$1.44M | |
| 2 | -$760K | |
| 3 | -$32.3K | |
| 4 |
Renaissance Technologies
New York
|
-$32K |
| 5 |
Morgan Stanley
New York
|
-$30K |